» Articles » PMID: 40004246

Metformin's Effects on Cognitive Function from a Biovariance Perspective: A Narrative Review

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2025 Feb 26
PMID 40004246
Authors
Affiliations
Soon will be listed here.
Abstract

This study examines the effects of metformin on brain functions focusing on the variability of the results reported in the literature. While some studies suggest that metformin may have neuroprotective effects in diabetic patients, others report an insignificant impact of metformin on cognitive function, or even a negative effect. We propose that this inconsistency may be due to intrinsic cellular-level variability among individuals, which we term "biovariance". Biovariance persists even in demographically homogeneous samples due to complex and stochastic biological processes. Additionally, the complex metabolic actions of metformin, including its influence on neuroenergetics and neuronal survival, may produce different effects depending on individual metabolic characteristics.

References
1.
Kuate Defo A, Bakula V, Pisaturo A, Labos C, Wing S, Daskalopoulou S . Diabetes, antidiabetic medications and risk of dementia: A systematic umbrella review and meta-analysis. Diabetes Obes Metab. 2023; 26(2):441-462. DOI: 10.1111/dom.15331. View

2.
Feng J, Wang X, Ye X, Ares I, Lopez-Torres B, Martinez M . Mitochondria as an important target of metformin: The mechanism of action, toxic and side effects, and new therapeutic applications. Pharmacol Res. 2022; 177:106114. DOI: 10.1016/j.phrs.2022.106114. View

3.
Salvatore T, Pafundi P, Galiero R, Rinaldi L, Caturano A, Vetrano E . Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects?. Biomedicines. 2020; 9(1). PMC: 7822116. DOI: 10.3390/biomedicines9010003. View

4.
Ziqubu K, Mazibuko-Mbeje S, Mthembu S, Mabhida S, Jack B, Nyambuya T . Anti-Obesity Effects of Metformin: A Scoping Review Evaluating the Feasibility of Brown Adipose Tissue as a Therapeutic Target. Int J Mol Sci. 2023; 24(3). PMC: 9917329. DOI: 10.3390/ijms24032227. View

5.
Michailidis M, Moraitou D, Tata D, Kalinderi K, Papamitsou T, Papaliagkas V . Alzheimer's Disease as Type 3 Diabetes: Common Pathophysiological Mechanisms between Alzheimer's Disease and Type 2 Diabetes. Int J Mol Sci. 2022; 23(5). PMC: 8910482. DOI: 10.3390/ijms23052687. View